Moxifloxacin hypersensitivity: Uselessness of skin testing

Journal of Allergy and Clinical Immunology: In Practice

Volumn 3, Issue 3, 2015, Pages 443-445

  Uyttebroek, Astrid P ^a   Sabato, Vito ^a   Bridts, Chris H ^a   De Clerck, Luc S ^a   Ebo, Didier G ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ABDOMINAL CRAMP; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FATTY ACID DESATURATION; FEMALE; HEART PALPITATION; HUMAN; HYPOTENSION; INTERMETHOD COMPARISON; INTRACUTANEOUS TEST; MALE; MIDDLE AGED; NAUSEA; PREDICTIVE VALUE; PROVOCATION TEST; SENSITIVITY AND SPECIFICITY; SKIN PRICK TEST; SKIN TEST; STRIDOR; TACHYCARDIA; UNCONSCIOUSNESS; URTICARIA; VERTIGO; VOMITING; IMMUNOLOGY; REPRODUCIBILITY; UNNECESSARY PROCEDURE;

ADULT; ANTI-BACTERIAL AGENTS; DRUG HYPERSENSITIVITY; FEMALE; FLUOROQUINOLONES; HUMANS; INTRADERMAL TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; UNNECESSARY PROCEDURES;

EID: 84946042863     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2014.12.012     Document Type: Article

References (11)

1. Jones S.C., Budnitz D.S., Sorbello A., Mehta H. US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions. Pharmacoepidemiol Drug Saf 2013, 22:1099-1106.
2. Empedrad R., Darter A.L., Earl H.S., Gruchalla R.S. Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 2003, 112:629-630.
3. Broz P., Harr T., Hecking C., Grize L., Scherer K., Jaeger K.A., et al. Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin. Allergy 2012, 67:647-652.
4. Brockow K., Garvey L.H., Aberer W., Atanaskovic-Markovic M., Barbaud A., Bilo M.B., et al. Skin test concentrations for systemically administered drugs-an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013, 68:702-712.
5. Gonzalez-Mancebo E., Fernandez-Rivaz M. Immediate hypersensitivity to levofloxacin diagnosed through skin prick test. Ann Pharmacother 2004, 38:354.
6. Seitz C.S., Bröcker E.B., Trautmann A. Diagnostic testing in suspected fluoroquinolone hypersensitivity. Clin Exp Allergy 2009, 39:1738-1745.
7. Ben Said B., Berard F., Bienvenu J., Nicolas J., Rozieres A. Usefulness of basophil activation tests for the diagnosis of IgE-mediated allergy to quinolones. Allergy 2010, 65:531-536.
8. Chang B., Knowles S.R., Weber E. Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature. Ann Pharmacother 2010, 44:740-745.
9. Sanchez-Morillas L., Rojas Perez-Ezquerra P., Reano-Martos M., Laguna-Martinez J., Gomez-Tembleque P. Systematic anaphylaxis caused by moxifloxacin. Allergol Immunopathol (Madr) 2010, 38:226-227.
10. Blanca-López N., Ariza A., Doña I., Mayorga C., Montañez M.I., Garcia-Campos J., et al. Hypersensitivity reactions to fluoroquinolones: analysis of the factors involved. Clin Exp Allergy 2013, 43:560-567.
11. Baldo B.A., Pham N.H. Drug Allergy. Clinical Aspects, Diagnosis, Mechanisms, Structure-Activity Relationships 2013, Springer, New York.